# A Trial of SHR-8068 Combined With Adebrelimab and Apatinib in Perioperative Treatment of Resectable Hepatocellular Carcinoma

> clinical trial · VERIFIED · 2026-07-02

Status: NOT_YET_RECRUITING · Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd. · Condition: Resectable Hepatocellular Carcinoma With Intermediate or High Recurrence Risk

- Company: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07682272

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.